Form 4: Zai Lab Executive Reports Stock Transactions

Zai Lab Ltd. executive Joshua L. Smiley reported transactions involving American Depositary Shares (ADSs) and equity awards, including the acquisition of shares upon vesting of Restricted Share Units and Performance-Based Share Units, and the sale of some shares to cover taxes.

Summary

• Joshua L. Smiley, President and Chief Operating Officer of Zai Lab Ltd., reported several transactions related to the company's American Depositary Shares (ADSs).
• On March 4, 2026, Performance-Based Share Units (PSUs) representing 17,887 ADSs were confirmed as vested based on performance criteria met between January 1, 2025, and December 31, 2025. These PSUs are scheduled to fully vest on March 12, 2028.
• On April 1, 2026, 32,062 ADSs were acquired upon the vesting of Restricted Share Units (RSUs). These RSUs vest in equal annual installments over four years, starting April 1, 2025.
• On April 2, 2026, an additional 7,145 ADSs were acquired upon the vesting of RSUs. These RSUs vest in equal annual installments over four years, starting April 3, 2024.
• Also on April 2, 2026, 9,614 ADSs were sold at a price of $20.39 per ADS to cover taxes associated with the vesting of RSUs.
• Following these transactions, Mr. Smiley beneficially owns 120,619 ADSs directly, with a total of 130,233 ADSs after the April 2nd transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions and equity award vesting without significant positive or negative financial news.

Positives

• Confirmation of vesting for 17,887 Performance-Based Share Units (PSUs) indicates achievement of performance targets.
• Acquisition of 32,062 ADSs upon RSU vesting suggests continued equity compensation and potential future value realization.
• Acquisition of 7,145 ADSs upon RSU vesting further indicates ongoing equity compensation.
• The reporting person continues to hold a significant number of ADSs (120,619 directly, 130,233 total after transactions).

Negatives

• Sale of 9,614 ADSs to cover taxes upon vesting of RSUs represents a reduction in the reporting person's direct holdings.

Risks

• The vesting of RSUs is subject to continuous service, meaning any departure from the company before the vesting date would result in forfeiture.
• The value of the vested and unvested equity awards is subject to market fluctuations of Zai Lab's American Depositary Shares (ADSs).

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions and the status of equity awards.

Management Comments

• The filing is a standard SEC Form 4 reporting beneficial ownership changes and is signed by an attorney-in-fact for the reporting person.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, providing transparency on their holdings and transactions. The details here reflect standard equity compensation practices within the biotechnology and pharmaceutical sectors, where Zai Lab operates.

Stakeholder Impact

• Shareholders: Increased transparency into executive holdings and potential future selling pressure from tax-related sales.
• Employees: The vesting of RSUs and PSUs for the COO indicates continued incentive alignment and potential for wealth creation.
• Creditors: No direct impact from this filing.

Next Steps

• Continued vesting of RSUs over the next several years, subject to continuous service.
• Full vesting of PSUs on March 12, 2028, subject to continuous service.

Key Dates

Keywords

Zai Lab Ltd, Joshua L. Smiley, Form 4, SEC Filing, Stock Transaction, ADS, RSU, PSU, Vesting, Equity Compensation, Beneficial Ownership